Drugs / JWK007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06114056 | Jan 2024 → Nov 2029 expected | Duchenne muscular dystrophy | West China Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JWK007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06114056 ↗ |
| Known as | AAVM101-µDys | “JWK007 (AAVM101-µDys)” NCT06114056 ↗ |
| Route | Intravenous | “single intravenous infusion of JWK007” NCT06114056 ↗ |